Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Tirzepatide is a biologic drug, a 39-amino-acid peptide with a fatty acid modification that gives it its extended half-life
Tirzepatide is FDA-approved for diabetes treatment and weight loss, while Retatrutide is still in clinical trials
It is not intended for human or animal use, consumption, administration, or application under any circumstances
It is also not for children or people with type 1 diabetes
Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barretts epithelium
US$ 26.63
US$ 22.33
US$ 22.38
US$ 25.95
US$ 24.76
US$ 20.11
US$ 20.77
